Access to Innovation for Medicare Patients Act of 2003

Access to Innovation for Medicare Patients Act of 2003 - Amends title XVIII (Medicare) of the Social Security Act to provide for Medicare coverage of self-injected biologicals approved by the Food and Drug Administration that are prescribed as a complete replacement for a drug or a biological that otherwise cannot be self-administered.

[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H.R. 980 Introduced in House (IH)]







108th CONGRESS
  1st Session
                                H. R. 980

  To amend title XVIII of the Social Security Act to expand Medicare 
             coverage of certain self-injected biologicals.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           February 27, 2003

 Ms. Dunn (for herself, Mr. McDermott, Mr. Pickering, Mrs. Capps, Mr. 
     Inslee, Mr. Crane, Mr. Greenwood, Mr. Dicks, Mr. Hastings of 
 Washington, Mr. Abercrombie, Mr. McNulty, Mr. Kleczka, Mr. Paul, and 
  Mr. Frost) introduced the following bill; which was referred to the 
 Committee on Energy and Commerce, and in addition to the Committee on 
   Ways and Means, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
  To amend title XVIII of the Social Security Act to expand Medicare 
             coverage of certain self-injected biologicals.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Access to Innovation for Medicare 
Patients Act of 2003''.

SEC. 2. MEDICARE COVERAGE OF SELF-INJECTED BIOLOGICALS.

    (a) Coverage.--Section 1861(s)(2) of the Social Security Act (42 
U.S.C. 1395x(s)(2)) is amended--
            (1) by striking ``and'' at the end of subparagraph (U);
            (2) by inserting ``and'' at the end of subparagraph (V); 
        and
            (3) by adding at the end the following new subparagraph:
            ``(W) a self-injected biological (which is approved by the 
        Food and Drug Administration) that is prescribed as a complete 
        replacement for a drug or biological that would otherwise be 
        described in subparagraph (A) or (B);''.
    (b) Effective Date.--The amendments made by subsection (a) shall 
apply to biologicals furnished on or after January 1, 2004.
                                 <all>